INKT

NASDAQStock

MiNK Therapeutics, Inc.

$10.04-0.24 (-2.34%)

52-Week Range

$6.89

$64.17

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.35

Volume

105.5K

Avg Volume

1.2M

Performance

-6.88%

-15.60%

-27.96%

YTD

-7.55%

+21.11%

-49.61%

-91.43%

Price Chart

ETF Exposure

INKT is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	2	$38	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	86	$1K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$6	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	49,290	$581K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	259	$4K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	22	$356	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	10,074	$119K	$84.10B	0.05%

About INKT ETF Exposure

MiNK Therapeutics, Inc. (INKT) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $10.04. Investors can gain exposure to INKT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold INKT, sorted by portfolio weight.